BIODESIX, INC. (BDSX) Return on equity 2020–2024
BIODESIX, INC. (BDSX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-205.6%FY2024 · since FY2020: -159.0% → -205.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -205.6% | +932.9 pp |
| FY2023 | -1138.6% | -820.9 pp |
| FY2022 | -317.6% | -98.8 pp |
| FY2021 | -218.8% | -59.8 pp |
| FY2020 | -159.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BDSX financial trends
BDSX RevenueBDSX Net incomeBDSX Net marginBDSX Gross profitBDSX Gross marginBDSX Operating incomeBDSX Operating marginBDSX Operating cash flowBDSX Free cash flowBDSX Capital expendituresBDSX Stock buybacksBDSX Dividends paidBDSX Total assetsBDSX Total liabilitiesBDSX Shareholders’ equityBDSX overview →